Literature DB >> 25193657

A systematic review of the key factors affecting tissue viability and rehabilitation outcomes of the residual limb in lower extremity traumatic amputees.

Katrina Butler1, Catherine Bowen1, Ann-Marie Hughes1, Russel Torah2, Ivo Ayala2, John Tudor2, Cheryl D Metcalf3.   

Abstract

Most traumatic lower limb amputees ambulate using a prosthetic limb. Comfort, appearance of the missing limb and function are confirmed as being important during rehabilitation post-amputation. Emerging evidence suggests that impaired tissue viability of the stump affects rehabilitation and thus clinical ability to provide optimum care. The primary objective of this systematic review was to identify key factors relating to tissue viability of the residual limb in lower extremity traumatic amputees. A secondary objective was to identify factors that affect rehabilitation post-amputation. In total, 218 studies were assessed; 37 met pre-determined criteria. Studies were classified according to the WHO ICF framework and the NHMRC level of evidence. Five key themes emerged; Prosthetic Fit; The Residuum; Quality of Life; Amputee Care and Prosthetic Use. The evidence indicates that high frequencies of skin problems affecting tissue viability within this population are inherently linked to intolerance of the prosthesis. Stump integrity, amputee care regimen and pain were also identified as impacting on quality of life, affecting rehabilitation and the ability to become independently mobile. Levels of evidence within all studies were low and indicative of the majority being non-randomised cohort studies or case-control studies. As there are a limited number of interventional studies, further development of robust outcome measures, clinical trials and prospective studies are of utmost importance to unravel the links between tissue viability and the other key factors. This will inform clinical management strategies and help develop targeted therapies and care pathways.
Copyright © 2014 Tissue Viability Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amputation; Systematic review; Transfemoral; Transtibial; Trauma

Mesh:

Year:  2014        PMID: 25193657     DOI: 10.1016/j.jtv.2014.08.002

Source DB:  PubMed          Journal:  J Tissue Viability        ISSN: 0965-206X            Impact factor:   2.932


  5 in total

1.  Long-term outcomes following lower extremity press-fit bone-anchored prosthesis surgery: a 5-year longitudinal study protocol.

Authors:  Ruud A Leijendekkers; J Bart Staal; Gerben van Hinte; Jan Paul Frölke; Hendrik van de Meent; Femke Atsma; Maria W G Nijhuis-van der Sanden; Thomas J Hoogeboom
Journal:  BMC Musculoskelet Disord       Date:  2016-11-22       Impact factor: 2.362

Review 2.  Systematic Review of Studies Examining Transtibial Prosthetic Socket Pressures with Changes in Device Alignment.

Authors:  Philip Davenport; Siamak Noroozi; Philip Sewell; Saeed Zahedi
Journal:  J Med Biol Eng       Date:  2017-01-21       Impact factor: 1.553

3.  Complications of bone-anchored prostheses for individuals with an extremity amputation: A systematic review.

Authors:  Robin Atallah; Ruud A Leijendekkers; Thomas J Hoogeboom; Jan Paul Frölke
Journal:  PLoS One       Date:  2018-08-09       Impact factor: 3.240

4.  Elective transfemoral amputation and simultaneous implantation of a transcutaneous osseointegrated prosthesis stem as salvage treatment after knee joint arthrodesis with poor function: A case report.

Authors:  Katharina Krause; Katherina Richter; Thomas Beyer; Horst Heinrich Aschoff; Dagmar-Christiane Fischer; Thomas Mittlmeier
Journal:  Front Surg       Date:  2022-08-30

5.  Osseointegrated reconstruction and rehabilitation of transtibial amputees: the Osseointegration Group of Australia surgical technique and protocol for a prospective cohort study.

Authors:  Russel Haque; Shakib Al-Jawazneh; Jason Hoellwarth; Muhammad Adeel Akhtar; Karan Doshi; Yao Chang Tan; William Yenn-Ru Lu; Claudia Roberts; Munjed Al Muderis
Journal:  BMJ Open       Date:  2020-10-20       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.